Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Acta Neuropathologica

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s004010000355PMID 11585247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation

  2000cited by this paper
• Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses

  1999influential reference
• The Copper Chaperone CCS Is Abundant in Neurons and Astrocytes in Human and Rodent Brain

  1999influential reference
• New variations of human CC-chemokine receptors CCR3 and CCR4

  1999cited by this paper
• Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.

  1999cited by this paper
• Multiple Protein Domains Contribute to the Action of the Copper Chaperone for Superoxide Dismutase*

  1999influential reference
• The Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase*

  1998cited by this paper
• Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

  1998cited by this paper
• Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants.

  1998cited by this paper
• Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis.

  1997cited by this paper
• The Copper Chaperone for Superoxide Dismutase*

  1997cited by this paper
• Amyotrophic Lateral Sclerosis: Progress and Perspectives in Basic Research and Clinical Applications

  1997cited by this paper
• Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement

  1996influential reference
• Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes.

  1996cited by this paper
• Asymmetric involvement of the spinal cord involving both large and small anterior horn cells in a case of familial amyotrophic lateral sclerosis.

  1987cited by this paper
• Joint purification of mangano and cuprozinc superoxide dismutases from a single source--a simplified method.

  1984influential reference
• Hereditary Amyotrophic Lateral Sclerosis: Histochemical and Electron Microscopic Study of Hyaline Inclusions in Motor Neurons

  1972cited by this paper
• Hereditary amyotrophic lateral sclerosis. Histochemical and electron microscopic study of hyaline inclusions in motor neurons.

  1972cited by this paper
• Epidemiologic Investigations of Amyotrophic Lateral Sclerosis

  1955cited by this paper
• Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I.

  1955cited by this paper
• Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. II.

  1955cited by this paper

• Decoding Glycosylation in Neurodegenerative Diseases: Mechanistic Insights and Therapeutic Opportunities

  2025cites this paper
• New developments in pre-clinical models of ALS to guide translation.

  2024cites this paper
• Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases

  2023influential citation
• Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

  2022cites this paper
• Probing the polyphenolic flavonoid, morin as a highly efficacious inhibitor against amyloid(A4V) mutant SOD1 in fatal amyotrophic lateral sclerosis.

  2022cites this paper
• Immunohistochemical and ultrastructural evidence for the pathogenesis of white matter degeneration in patients with panencephalopathic‐type Creutzfeldt–Jakob disease: Inducible nitric oxide synthase overexpression in bizarre astrocytes

  2020cites this paper
• Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection

  2020cites this paper
• Protein aggregation in cell biology: An aggregomics perspective of health and disease.

  2020cites this paper
• The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis

  2019cites this paper
• Molecular binding response of naringin and naringenin to H46R mutant SOD1 protein in combating protein aggregation using density functional theory and discrete molecular dynamics.

  2019cites this paper
• Exploring the Extended Biological Functions of the Human Copper Chaperone of Superoxide Dismutase 1

  2019cites this paper
• Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis

  2019influential citation
• Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models

  2018cites this paper
• Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets

  2018cites this paper
• Deciphering the loss of metal binding due to mutation D83G of human SOD1 protein causing FALS disease.

  2018cites this paper
• Loss of charge at solvent exposed Lys residues does not induce the aggregation of superoxide dismutase 1

  2018cites this paper
• Cysteine to Serine Conversion at 111th Position Renders the Disaggregation and Retains the Stabilization of Detrimental SOD1 A4V Mutant Against Amyotrophic Lateral Sclerosis in Human—A Discrete Molecular Dynamics Study

  2017cites this paper
• Computational investigation of the human SOD1 mutant, Cys146Arg, that directs familial amyotrophic lateral sclerosis.

  2017cites this paper
• Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics.

  2017cites this paper
• Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations

  2016cites this paper
• A faulty interaction between SOD1 and hCCS in neurodegenerative disease

  2016cites this paper
• Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes

  2014cites this paper
• 20 Amyotrophic Lateral Sclerosis

  2014cites this paper
• Cerebellar Expression of Copper Chaperone for Superoxide, Cytosolic Cu/Zn-Superoxide Dismutase, 4-Hydroxy-2-Nonenal, Acrolein and Heat Shock Protein 32 in Patients with Menkes Kinky Hair Disease: Immunohistochemical Study

  2014cites this paper
• Role of stearoyl-CoA desaturase-1 in maintaining muscle activity : study of a lesion model for understanding the meatbolic alterations characteristics of amyotrophic lateral sclerosis

  2013cites this paper
• Amyotrophic Lateral Sclerosis Progress and Prospects for Treatment

  2012cites this paper
• Degenerative Neurological and Neuromuscular Disease Amyotrophic lateral sclerosis : update and new developments

  2012cites this paper
• Protein Misfolding and Toxicity in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Amyotrophic lateral sclerosis: update and new developments.

  2012cites this paper
• Copper uptake and trafficking in the brain

  2012cites this paper
• Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

  2011cites this paper
• The structural biochemistry of the superoxide dismutases.

  2010cites this paper
• Ultrastructural diversity of inclusions and aggregations in the lumbar spinal cord of SOD1-G93A transgenic mice.

  2010cites this paper
• Amyotrophic lateral sclerosis.

  2010cites this paper
• Copper–Zinc Superoxide Dismutase, Its Copper Chaperone, and Familial Amyotrophic Lateral Sclerosis

  2010cites this paper
• Implication of detergent-insoluble aggregates of superoxide dismutase 1 in familial amyotrophic lateral sclerosis

  2009cites this paper
• Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis

  2009cites this paper
• Role of Pro-Apoptotic BCL2-homology-3 Domain (BH3)-only Proteins in the Mutant SOD1 Mouse Model of ALS

  2009influential citation
• Interaction of Amyotrophic Lateral Sclerosis (ALS)-related Mutant Copper-Zinc Superoxide Dismutase with the Dynein-Dynactin Complex Contributes to Inclusion Formation*

  2008cites this paper
• Chapter 4 Molecular mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis.

  2007cites this paper
• Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.

  2007cites this paper
• Spectroscopic studies of the human copper chaperone for superoxide dismutase probing the active cluster with selenocysteine variants

  2007cites this paper
• An In Vitro Model for Lewy Body-Like Hyaline Inclusion/Astrocytic Hyaline Inclusion: Induction by ER Stress with an ALS-Linked SOD1 Mutation

  2007cites this paper
• Inverse correlation between the formation of mitochondria-derived vacuoles and Lewy-body-like hyaline inclusions in G93A superoxide-dismutase-transgenic mice

  2006cites this paper
• Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.

  2006cites this paper
• Posttranslational Modifications in Cu,Zn-Superoxide Dismutase and Mutations Associated with Amyotrophic Lateral Sclerosis

  2006cites this paper
• Superoxide dismutase 1 and amyotrophic lateral sclerosis

  2005cites this paper
• Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models

  2004cites this paper
• PARP Expression Is Increased in Astrocytes but Decreased in Motor Neurons in the Spinal Cord of Sporadic ALS Patients

  2003cites this paper
• Genetic epidemiology of amyotrophic lateral sclerosis

  2003cites this paper
• Amyotrophic lateral sclerosis: progress and prospects for treatment.

  2003cites this paper
• Protein aggregation in motor neurone disorders

  2003cites this paper
• Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis.

  2003cites this paper
• ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization.

  2003cites this paper
• Chapter 9 Cellular Biological Effects of Copper/Zinc Superoxide Dismutase Mutations

  2003cites this paper
• Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase.

  2002cites this paper
• Immunohistochemical analysis of copper chaperone for superoxide dismutase in mouse central nervous system; a comparative study with paraffin and frozen section

  2002cites this paper
• Differential amplification of gene expression in lens cell lines conditioned to survive peroxide stress.

  2002cites this paper